Skip to main content

Table 2 Quantification of the MDV genome in peripheral blood mononuclear cells from chickens in the test groups (mean ± SD, n= 6).

From: Genetic interference exerted by Salmonella-delivered CRISPR/Cas9 significantly reduces the pathological burden caused by Marek’s disease virus in chickens

Day

Gene

Group

A

B

C

D

E

7

meq

Nd

2.7 ± 1.9

0.6 ± 0.3

0.3 ± 0.3

2.5 ± 2.3

 

ovo

 

1446.1 ± 1140.8

644.2 ± 222.1

583.6 ± 240.5

549.1 ± 270.0

14

meq

Nd

10.6 ± 7.9

8.4 ± 4.4

2.4 ± 2.0

5.6 ± 4.1

 

ovo

 

620.5 ± 670.7

537.5 ± 518.9

512.7 ± 197.4

517.1 ± 244.1

21

meq

Nd

431.9 ± 254.6

247.5 ± 127.4

490.4 ± 13.9

591.3 ± 343.8

 

ovo

 

442.6 ± 212.9

456.5 ± 459.3

490.4 ± 13.9

591.3 ± 343.8

28

meq

Nd

5941.1 ± 2975.2

2060.1 ± 1174.5

777.4 ± 430.0*

6156.8 ± 4637.6

 

ovo

 

404.1 ± 140.2

525.7 ± 259.1

468.1 ± 259.1

315.2 ± 186.7

  1. Gene copy number × 103/105 cells.
  2. The chicken was subjected to Salmonella-mediated CRISPR treatment and experimental infection with MDV as follows. A: Naïve, B: PBS control, C: 1st—MDV infection, D: 1stSalmonella infection, E: vector control. Viral copy numbers were determined in peripheral blood mononuclear cells (PBMCs) on the 7th, 14th, 21st, and 28th days post-treatment. Using the meq gene (target) and the ovo gene (housekeeping gene) viral copy numbers were determined and each group was compared against the PBS control for each collection day. A significant reduction in viral copy numbers was observed only in group D birds by the 28th day compared to the PBS control group. This result highlights the importance of timing of Salmonella treatment to significantly reduce the impact of MDV infection. Before the MDV infection, Salmonella infection must take place to deliver the CRIPSR plasmid for effective interception of viral genome. The level of significance was determined if the p < 0.05 (in bold italic).
  3. *Indicates a significant difference in viral copy number compared to the PBS control group (p < 0.05).